UnitedHealth Group Incorporated (NYSE:UNH) Position Increased by Evanson Asset Management LLC

Evanson Asset Management LLC raised its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 38.4% in the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,070 shares of the healthcare conglomerate’s stock after buying an additional 297 shares during the period. Evanson Asset Management LLC’s holdings in UnitedHealth Group were worth $550,000 as of its most recent SEC filing.

Other large investors have also recently added to or reduced their stakes in the company. Advocacy Wealth Management Services LLC lifted its position in shares of UnitedHealth Group by 75.8% in the 1st quarter. Advocacy Wealth Management Services LLC now owns 58 shares of the healthcare conglomerate’s stock valued at $30,000 after acquiring an additional 25 shares in the last quarter. Cascade Investment Advisors Inc. lifted its position in shares of UnitedHealth Group by 100.0% in the 1st quarter. Cascade Investment Advisors Inc. now owns 60 shares of the healthcare conglomerate’s stock valued at $31,000 after acquiring an additional 30 shares in the last quarter. Rise Advisors LLC purchased a new stake in shares of UnitedHealth Group in the 4th quarter valued at approximately $38,000. Evolution Advisers Inc. purchased a new stake in UnitedHealth Group in the 1st quarter worth approximately $38,000. Finally, Cordant Inc. purchased a new stake in UnitedHealth Group in the 1st quarter worth approximately $45,000. 87.25% of the stock is currently owned by institutional investors.

Insider Transactions at UnitedHealth Group

In other news, Director Stephen J. Hemsley sold 99,312 shares of the firm’s stock in a transaction dated Tuesday, July 26th. The shares were sold at an average price of $534.27, for a total transaction of $53,059,422.24. Following the completion of the transaction, the director now directly owns 787,372 shares of the company’s stock, valued at approximately $420,669,238.44. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In related news, Director Stephen J. Hemsley sold 99,312 shares of UnitedHealth Group stock in a transaction dated Tuesday, July 26th. The shares were sold at an average price of $534.27, for a total transaction of $53,059,422.24. Following the completion of the transaction, the director now directly owns 787,372 shares of the company’s stock, valued at approximately $420,669,238.44. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CAO Thomas E. Roos sold 465 shares of UnitedHealth Group stock in a transaction dated Friday, August 26th. The shares were sold at an average price of $542.37, for a total transaction of $252,202.05. Following the transaction, the chief accounting officer now directly owns 34,786 shares of the company’s stock, valued at $18,866,882.82. The disclosure for this sale can be found here. In the last three months, insiders sold 139,051 shares of company stock valued at $74,450,958. Company insiders own 0.40% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have issued reports on UNH shares. SVB Leerink increased their target price on shares of UnitedHealth Group from $600.00 to $625.00 and gave the stock an “outperform” rating in a research report on Monday, July 18th. Raymond James increased their target price on shares of UnitedHealth Group from $620.00 to $635.00 in a research report on Thursday. Oppenheimer raised their price target on shares of UnitedHealth Group from $600.00 to $610.00 and gave the company an “outperform” rating in a report on Monday, July 18th. UBS Group raised their price target on shares of UnitedHealth Group from $545.00 to $570.00 and gave the company a “neutral” rating in a report on Thursday, July 21st. Finally, BMO Capital Markets raised their price target on shares of UnitedHealth Group from $600.00 to $610.00 in a report on Wednesday, July 20th. Three research analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat, UnitedHealth Group has an average rating of “Moderate Buy” and an average target price of $586.40.

UnitedHealth Group Stock Performance

NYSE UNH opened at $517.46 on Friday. The company has a debt-to-equity ratio of 0.60, a current ratio of 0.77 and a quick ratio of 0.77. The firm has a market capitalization of $484.02 billion, a price-to-earnings ratio of 27.02, a P/E/G ratio of 1.61 and a beta of 0.76. The company’s fifty day moving average is $530.11 and its two-hundred day moving average is $512.45. UnitedHealth Group Incorporated has a 52-week low of $383.12 and a 52-week high of $553.29.

UnitedHealth Group (NYSE:UNHGet Rating) last posted its quarterly earnings results on Friday, July 15th. The healthcare conglomerate reported $5.57 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.24 by $0.33. The company had revenue of $80.33 billion for the quarter, compared to analyst estimates of $79.68 billion. UnitedHealth Group had a net margin of 5.95% and a return on equity of 25.45%. The business’s quarterly revenue was up 12.6% on a year-over-year basis. During the same period last year, the business posted $4.70 EPS. Equities research analysts forecast that UnitedHealth Group Incorporated will post 21.85 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 20th. Stockholders of record on Monday, September 12th were issued a dividend of $1.65 per share. This represents a $6.60 dividend on an annualized basis and a dividend yield of 1.28%. The ex-dividend date was Friday, September 9th. UnitedHealth Group’s payout ratio is 34.46%.

UnitedHealth Group Company Profile

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Recommended Stories

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHGet Rating).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.